TCG Labs Soleil’s Juri Biosciences is offering EpimAb Biotherapeutics up to $210 million biobucks for exclusive licensing ...

On May 9, 2025, the Tianjin Municipal Administration for Market Regulation (“Tianjin AMR”) announced administrative penalties ...

- Establishing High-quality Pharmaceutical Logistics Service Systems - ...

With the goal to become a top 3 pharma company in China, Novartis has been busy tapping into the expertise of local ...

Indian CDMOs are strategically expanding through acquisitions in the US and Europe, driven by global pharma's nearshoring ...

The China NMPA's CDE has granted breakthrough therapy designation approval to Abbisko Therapeutics’ irpagratinib for HCC.

China's Livzon Pharmaceutical Group Inc. will spend VND5.73 trillion ($221 million) to acquire almost 65 per cent of ...

The National Healthcare Security Administration will soon release a revised version of the Drug Pricing and Procurement ...

L’Oréal Groupe has backed Chinese biotech start-up Veminsyn to help identify new ingredients and speed up the process of ...

3SBio's shares surged 32% to 19.18 Hong Kong dollars, equivalent to US$2.45, on Tuesday after the Chinese company said it would receive an upfront payment of US$1.25 billion and potential milestone ...

As geopolitical tensions prompt global pharmaceutical giants to pivot away from China, India's Contract Development and ...